Exposure to allopurinol and the risk of cataract extraction in elderly patients

Archives of Ophthalmology

Volumn 116, Issue 12, 1998, Pages 1652-1656

  Garbe, Edeltraut ^a   Suissa, Samy ^b   LeLorier, Jacques ^c  

^a Potsdam Inst P   (Germany)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL;

AGED; ARTICLE; CASE CONTROL STUDY; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032424291     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.12.1652     Document Type: Article

References (29)

1. Emmerson BT. The management of gout. N Engl J Med. 1996;446:445-451.
2. Fraunfelder FT, Hanna C, Dreis MW, Cosgrove KW Jr. Cataracts associated with allopurinol therapy. Am J Ophthalmol. 1982;94:137-140.
3. Lerman S, Megaw JM, Gardner K. Allopurinol therapy and cataractogenesis in humans. Am J Ophthalmol. 1982;94:141-146.
4. Lerman S, Megaw JM, Fraunfelder FT. Further studies on allopurinol therapy and human cataractogenesis. Am J Ophthalmol. 1984;97:205-209.
5. Jick H, Brandt DE. Allopurinol and cataracts. Am J Ophthalmol. 1984;98: 355-358.
6. Clair WK, Chylack LTJ, Cook EF, Goldman L. Allopurinol use and the risk of cataract formation. Br J Ophthalmol. 1989;73:173-176.
7. Liu CS, Brown NA, Leonard TJ, Bull PW, Scott JT. The prevalence and morphology of cataract in patients on allopurinol treatment. Eye. 1988;2:600-606.
8. Leske MC, Chylack LT, Wu S-Y, The Lens Opacities Case-Control Study Group. The Lens Opacities Case-Control Study: risk factors for cataract. Arch Ophthalmol. 1991;109:244-251.
9. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
10. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995; 48:999-1009.
11. SAS Institute Inc. The PHREG procedure. In: SAS Technical Report P-299: SAS/ STAT Software: Changes and Enhancements, Release 6.07. Cary, NC: SAS Institute Inc; 1992:435-479.
12. Shapiro S. The role of automated record linkage in the postmarketing surveillance of drug safety: a critique. Clin Pharmacol Ther. 1989;46:371-386.
13. Livingston PM, Carson CA, Taylor HR. The epidemiology of cataract: a review of the literature. Ophthalmic Epidemiol. 1995;2:151-164.
14. Leske MC, Sperduto RD. The epidemiology of senile cataracts: a review. Am J Epidemiol. 1983;118:152-165.
15. Hodge WG, Whitcher JP, Satariano W. Risk factors for age-related cataracts. Epidemiol Rev. 1995;17:336-346.
16. West SK, Valmadrid CT. Epidemiology of risk factors for age-related cataract. Surv Ophthalmol. 1995;39:323-334.
17. Klein BEK, Klein R, Jensen SC, Linton KLP. Hypertension and lens opacities from the Beaver Dam Eye Study. Am J Ophthalmol. 1995;119:640-646.
18. Bonomi L. Cataracts induced by topical ocular medications. Dev Ophthalmol. 1989; 17:196-198.
19. Harding JJ, Egerton M, van Heyningen R, Harding RS. Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case-control studies. Br J Ophthalmol. 1993;77:2-6.
20. van Heyningen R, Harding JJ. Do aspirin-like analgesics protect against cataract? a case-control study. Lancet. 1986;1:1111-1113.
21. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics. 1993;92:64-77.
22. Isaac NE, Walker AM, Jick H, Gorman M. Exposure to phenothiazine drugs and risk of cataract. Arch Ophthalmol. 1991;109:256-260.
23. Bochow TW, West SK, Azar A, Munoz B, Sommer A, Taylor HR. Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch Ophthalmol. 1989; 107:369-372.
24. Walker AM, Jick H, Gorman MR, Wallach RW. Steroids, diabetes, analgesics, and the risk of cataract: lessons from the epidemiology of cataract extraction. J Clin Res Drug Dev. 1988;2:227-232.
25. Harding JJ, van Heyningen R. Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide. Br J Ophthalmol. 1988;72:809-814.
26. Dolezal JM, Perkins ES, Wallace RB. Sunlight, skin sensitivity, and senile cataract. Am J Epidemlol. 1989;129:559-568.
27. Munoz B, Tajchman U, Bochow T, West S. Alcohol use and risk of posterior subcapsular opacities. Arch Ophthalmol. 1993;111:110-112.
28. Lerman S. Evaluation of risk factors in human cataractogenesis. Dev Ophthalmol. 1991;21:120-128.
29. Jaanus SD. Drug-related cataract. Optometry Clin. 1991;1:143-157.